Document is current
Any future updates will be listed below
-
Authors
Kastner, Randee https://orcid.org/0000-0003-3682-3255
López-Medina, Eduardo https://orcid.org/0000-0003-3066-5938
Sirivichayakul, Chukiat
Biswal, Shibadas
Escudero, Ian https://orcid.org/0009-0000-5254-6396
Folschweiller, Nicolas
Roubinis, Nicholas
Tricou, Vianney https://orcid.org/0000-0002-5465-8647
Tuboi, Suely https://orcid.org/0000-0003-3612-231X
Weil, John
- License Information
-
More Information
Article History
Received: 17 July 2025
Accepted: 9 June 2026
First Online: 8 July 2026
Competing interests
: E.L.-M. holds research funds, has received lecture honoraria from Takeda and has received grants from GSK, Sanofi Pasteur, Janssen, MSD and Moderna. C.S. has nothing to declare beyond Takeda sponsoring this trial. R.K., S.B., I.E., N.F., N.R., V.T., S.T. and J.W. were full-time employees of Takeda Pharmaceuticals International AG at the time of writing this manuscript and may hold shares in the company.
